During the past decade, Dynamik Research conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Dynamik Research" #1 collaborator was "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Dynamik Research" are "Benign Prostatic Hypertrophy" (1 trials) and "Diabetes Mellitus, Type 2" (1 trials). Many other conditions were trialed in "Dynamik Research" in a lesser frequency.

Most popular intervention types in "Dynamik Research" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Cetrorelix 78 mg + 52 mg" (1 trials), "Cetrorelix 78 mg + 78 mg" (1 trials), "Placebo" (1 trials), "glimepiride" (1 trials) and "glimepiride placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Dynamik Research" are 1 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Dynamik Research". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Dynamik Research, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Dynamik Research, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".